Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
22/05/2026 02:39
May 22 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK: MARKETING APPLICATION FOR M701 ACCEPTED BY CHINA CDE IN MAY 2026 Further company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit